Search research articles
Contact Us
Filters
Showing results (71-80 of 87) with videos related to
Page
of 9
Sort By:
Oncotarget
|
April 18, 2018
Promotion of malignant phenotype after disruption of the three-dimensional structure of cultured spheroids from colorectal cancer
Jose M Piulats, Jumpei Kondo, Hiroko Endo, et al.
Biochemical and Biophysical Research Communications
|
March 5, 2011
Oncogenicity of L-type amino-acid transporter 1 (LAT1) revealed by targeted gene disruption in chicken DT40 cells: LAT1 is a promising molecular target for human cancer therapy
Mayumi Ohkawa, Yoshiya Ohno, Kazue Masuko, et al.
Cancer Science
|
July 16, 2013
Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia
Takeyuki Wada, Takatsugu Ishimoto, Ryo Seishima, et al.
Cancer Research
|
January 16, 2013
xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma
Momoko Yoshikawa, Kenji Tsuchihashi, Takatsugu Ishimoto, et al.
Plos One
|
November 17, 2015
Immuno-PET Imaging of HER3 in a Model in which HER3 Signaling Plays a Critical Role
Qinghua Yuan, Takako Furukawa, Takahiro Tashiro, et al.
Cancer Science
|
December 15, 2018
Anti-tumor effects of mAb against L-type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modes
Shiho Ueda, Hidemi Hayashi, Takako Miyamoto, et al.
International Journal of Molecular Sciences
|
May 28, 2022
In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized <sup>64</sup>Cu-Intraperitoneal Radioimmunotherapy against Peritoneal Dissemination of Pancreatic Cancer: A Feasibility Study
Fukiko Hihara, Hiroki Matsumoto, Mitsuyoshi Yoshimoto, et al.
Oncotarget
|
February 1, 2020
Novel functional anti-HER3 monoclonal antibodies with potent anti-cancer effects on various human epithelial cancers
Kouki Okita, Shogo Okazaki, Shinya Uejima, et al.
FEBS Open Bio
|
January 6, 2025
CD44v, S1PR1, HER3, MET and cancer-associated amino acid transporters are promising targets for the pancreatic cancers characterized using mAb
Takashi Nakano, Kouki Okita, Shogo Okazaki, et al.
American Journal of Respiratory Cell and Molecular Biology
|
March 22, 2019
Endothelial-Mesenchymal Transition Drives Expression of CD44 Variant and xCT in Pulmonary Hypertension
Sarasa Isobe, Masaharu Kataoka, Jin Endo, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 87) with videos related to
Sort By:
Page
of 9
Oncotarget
|
April 18, 2018
Promotion of malignant phenotype after disruption of the three-dimensional structure of cultured spheroids from colorectal cancer
Jose M Piulats, Jumpei Kondo, Hiroko Endo, et al.
Biochemical and Biophysical Research Communications
|
March 5, 2011
Oncogenicity of L-type amino-acid transporter 1 (LAT1) revealed by targeted gene disruption in chicken DT40 cells: LAT1 is a promising molecular target for human cancer therapy
Mayumi Ohkawa, Yoshiya Ohno, Kazue Masuko, et al.
Cancer Science
|
July 16, 2013
Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia
Takeyuki Wada, Takatsugu Ishimoto, Ryo Seishima, et al.
Cancer Research
|
January 16, 2013
xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma
Momoko Yoshikawa, Kenji Tsuchihashi, Takatsugu Ishimoto, et al.
Plos One
|
November 17, 2015
Immuno-PET Imaging of HER3 in a Model in which HER3 Signaling Plays a Critical Role
Qinghua Yuan, Takako Furukawa, Takahiro Tashiro, et al.
Cancer Science
|
December 15, 2018
Anti-tumor effects of mAb against L-type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modes
Shiho Ueda, Hidemi Hayashi, Takako Miyamoto, et al.
International Journal of Molecular Sciences
|
May 28, 2022
In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized <sup>64</sup>Cu-Intraperitoneal Radioimmunotherapy against Peritoneal Dissemination of Pancreatic Cancer: A Feasibility Study
Fukiko Hihara, Hiroki Matsumoto, Mitsuyoshi Yoshimoto, et al.
Oncotarget
|
February 1, 2020
Novel functional anti-HER3 monoclonal antibodies with potent anti-cancer effects on various human epithelial cancers
Kouki Okita, Shogo Okazaki, Shinya Uejima, et al.
FEBS Open Bio
|
January 6, 2025
CD44v, S1PR1, HER3, MET and cancer-associated amino acid transporters are promising targets for the pancreatic cancers characterized using mAb
Takashi Nakano, Kouki Okita, Shogo Okazaki, et al.
American Journal of Respiratory Cell and Molecular Biology
|
March 22, 2019
Endothelial-Mesenchymal Transition Drives Expression of CD44 Variant and xCT in Pulmonary Hypertension
Sarasa Isobe, Masaharu Kataoka, Jin Endo, et al.
Page
of 9